Global Pigmented Lesion Treatment

Pigmented Lesion Treatment Comprehensive Study by Type (Energy Based Devices, RF Devices, Ultrasound Devices, IPL Devices), Application (Dermatology Clinics, Beauty Clinics, Hospitals), Treatment (Laser Treatment, Light-based Treatment, Others), Indication (Non-Metalic Lesions, Melanocytic Lesions) Players and Region - Global Market Outlook to 2026

Pigmented Lesion Treatment Market by XX Submarkets | Forecast Years 2022-2027  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Pigmented Lesion Treatment Market Scope
Pigmented lesions are skin lesions that are brown, black or blue in color. These lesions are most often melanocytic. However, non-melanocytic lesions can also be pigmented, particularly in dark-skinned individuals.and these lesions are keratinocytic, vascular, or reactive. These pigmented lesions are caused by melanocyte cells in the skin. These cells are the cells that produce melanin, the substance that gives color (pigment) to the skin.

The companies are exploring the market by adopting expansions, investments, new service launches and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions across the globe to gain competitive advantage through combined collaborations. Research Analyst at AMA estimates that United States Players will contribute to the maximum growth of Global Pigmented Lesion Treatment market throughout the predicted period.

Alma Lasers, Ltd. (Israel), Sciton, Inc. (United States), EL.En. S.p.A. (Italy), Lynton Lasers Ltd (United Kingdom), Solta Medical Inc. (United States), Lumenis Ltd. (Israel), Cynosure, Inc. (United States), Strata Skin Sciences, Inc. (United States), Syneron Medical Ltd. (United States) and Lutronic Corporation (South Korea) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research are Cutera Inc. (United States).

About Approach
The research aims to propose a patent-based approach in searching for potential technology partners as a supporting tool for enabling open innovation. The study also proposes a systematic searching process of technology partners as a
preliminary step to select the emerging and key players that are involved in implementing market estimations. While patent analysis is employed to overcome the aforementioned data- and process-related limitations, as expenses occurred in that technology allows us to estimate the market size by evolving segments as target market from total available market.

Segmentation Overview
The study have segmented the market of Global Pigmented Lesion Treatment market by Type (Energy Based Devices, RF Devices, Ultrasound Devices and IPL Devices), by Application (Dermatology Clinics, Beauty Clinics and Hospitals) and Region with country level break-up.

On the basis of geography, the market of Pigmented Lesion Treatment has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).




Market Trend
  • Increased Awareness among People about Healthy Lifestyle
  • High Rate of Adoption of Laser Technologies

Market Drivers
  • Increased Prevalence of Pigmented Lesion
  • Increased Number of Diagnostic Centres and Hospitals in Developing Countries

Opportunities
  • Increased Investment in the Research and Development Activities
  • Huge Investment by Major Players

Restraints
  • High Cost of Pigmented Lesion Treatment
  • Lack of Skilled Professionals

Challenges
  • Stringent Government Rules and Regulations


Key Target Audience
Pigmented Lesion Treatment Providers, Research Professionals, Emerging Companies and End-users

Report Objectives / Segmentation Covered

By Type
  • Energy Based Devices
  • RF Devices
  • Ultrasound Devices
  • IPL Devices
By Application
  • Dermatology Clinics
  • Beauty Clinics
  • Hospitals
By Treatment
  • Laser Treatment
  • Light-based Treatment
  • Others

By Indication
  • Non-Metalic Lesions
  • Melanocytic Lesions

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increased Prevalence of Pigmented Lesion
      • 3.2.2. Increased Number of Diagnostic Centres and Hospitals in Developing Countries
    • 3.3. Market Challenges
      • 3.3.1. Stringent Government Rules and Regulations
    • 3.4. Market Trends
      • 3.4.1. Increased Awareness among People about Healthy Lifestyle
      • 3.4.2. High Rate of Adoption of Laser Technologies
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Pigmented Lesion Treatment, by Type, Application, Treatment, Indication and Region (value) (2015-2020)
    • 5.1. Introduction
    • 5.2. Global Pigmented Lesion Treatment (Value)
      • 5.2.1. Global Pigmented Lesion Treatment by: Type (Value)
        • 5.2.1.1. Energy Based Devices
        • 5.2.1.2. RF Devices
        • 5.2.1.3. Ultrasound Devices
        • 5.2.1.4. IPL Devices
      • 5.2.2. Global Pigmented Lesion Treatment by: Application (Value)
        • 5.2.2.1. Dermatology Clinics
        • 5.2.2.2. Beauty Clinics
        • 5.2.2.3. Hospitals
      • 5.2.3. Global Pigmented Lesion Treatment by: Treatment (Value)
        • 5.2.3.1. Laser Treatment
        • 5.2.3.2. Light-based Treatment
        • 5.2.3.3. Others
      • 5.2.4. Global Pigmented Lesion Treatment by: Indication (Value)
        • 5.2.4.1. Non-Metalic Lesions
        • 5.2.4.2. Melanocytic Lesions
      • 5.2.5. Global Pigmented Lesion Treatment Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
  • 6. Pigmented Lesion Treatment: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2020)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Alma Lasers, Ltd. (Israel)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Sciton, Inc. (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. EL.En. S.p.A. (Italy)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Lynton Lasers Ltd (United Kingdom)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Solta Medical Inc. (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Lumenis Ltd. (Israel)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Cynosure, Inc. (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Strata Skin Sciences, Inc. (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Syneron Medical Ltd. (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Lutronic Corporation (South Korea)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Pigmented Lesion Treatment Sale, by Type, Application, Treatment, Indication and Region (value) (2021-2026)
    • 7.1. Introduction
    • 7.2. Global Pigmented Lesion Treatment (Value)
      • 7.2.1. Global Pigmented Lesion Treatment by: Type (Value)
        • 7.2.1.1. Energy Based Devices
        • 7.2.1.2. RF Devices
        • 7.2.1.3. Ultrasound Devices
        • 7.2.1.4. IPL Devices
      • 7.2.2. Global Pigmented Lesion Treatment by: Application (Value)
        • 7.2.2.1. Dermatology Clinics
        • 7.2.2.2. Beauty Clinics
        • 7.2.2.3. Hospitals
      • 7.2.3. Global Pigmented Lesion Treatment by: Treatment (Value)
        • 7.2.3.1. Laser Treatment
        • 7.2.3.2. Light-based Treatment
        • 7.2.3.3. Others
      • 7.2.4. Global Pigmented Lesion Treatment by: Indication (Value)
        • 7.2.4.1. Non-Metalic Lesions
        • 7.2.4.2. Melanocytic Lesions
      • 7.2.5. Global Pigmented Lesion Treatment Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Pigmented Lesion Treatment: by Type(USD Million)
  • Table 2. Pigmented Lesion Treatment Energy Based Devices , by Region USD Million (2015-2020)
  • Table 3. Pigmented Lesion Treatment RF Devices , by Region USD Million (2015-2020)
  • Table 4. Pigmented Lesion Treatment Ultrasound Devices , by Region USD Million (2015-2020)
  • Table 5. Pigmented Lesion Treatment IPL Devices , by Region USD Million (2015-2020)
  • Table 6. Pigmented Lesion Treatment: by Application(USD Million)
  • Table 7. Pigmented Lesion Treatment Dermatology Clinics , by Region USD Million (2015-2020)
  • Table 8. Pigmented Lesion Treatment Beauty Clinics , by Region USD Million (2015-2020)
  • Table 9. Pigmented Lesion Treatment Hospitals , by Region USD Million (2015-2020)
  • Table 10. Pigmented Lesion Treatment: by Treatment(USD Million)
  • Table 11. Pigmented Lesion Treatment Laser Treatment , by Region USD Million (2015-2020)
  • Table 12. Pigmented Lesion Treatment Light-based Treatment , by Region USD Million (2015-2020)
  • Table 13. Pigmented Lesion Treatment Others , by Region USD Million (2015-2020)
  • Table 14. Pigmented Lesion Treatment: by Indication(USD Million)
  • Table 15. Pigmented Lesion Treatment Non-Metalic Lesions , by Region USD Million (2015-2020)
  • Table 16. Pigmented Lesion Treatment Melanocytic Lesions , by Region USD Million (2015-2020)
  • Table 17. South America Pigmented Lesion Treatment, by Country USD Million (2015-2020)
  • Table 18. South America Pigmented Lesion Treatment, by Type USD Million (2015-2020)
  • Table 19. South America Pigmented Lesion Treatment, by Application USD Million (2015-2020)
  • Table 20. South America Pigmented Lesion Treatment, by Treatment USD Million (2015-2020)
  • Table 21. South America Pigmented Lesion Treatment, by Indication USD Million (2015-2020)
  • Table 22. Brazil Pigmented Lesion Treatment, by Type USD Million (2015-2020)
  • Table 23. Brazil Pigmented Lesion Treatment, by Application USD Million (2015-2020)
  • Table 24. Brazil Pigmented Lesion Treatment, by Treatment USD Million (2015-2020)
  • Table 25. Brazil Pigmented Lesion Treatment, by Indication USD Million (2015-2020)
  • Table 26. Argentina Pigmented Lesion Treatment, by Type USD Million (2015-2020)
  • Table 27. Argentina Pigmented Lesion Treatment, by Application USD Million (2015-2020)
  • Table 28. Argentina Pigmented Lesion Treatment, by Treatment USD Million (2015-2020)
  • Table 29. Argentina Pigmented Lesion Treatment, by Indication USD Million (2015-2020)
  • Table 30. Rest of South America Pigmented Lesion Treatment, by Type USD Million (2015-2020)
  • Table 31. Rest of South America Pigmented Lesion Treatment, by Application USD Million (2015-2020)
  • Table 32. Rest of South America Pigmented Lesion Treatment, by Treatment USD Million (2015-2020)
  • Table 33. Rest of South America Pigmented Lesion Treatment, by Indication USD Million (2015-2020)
  • Table 34. Asia Pacific Pigmented Lesion Treatment, by Country USD Million (2015-2020)
  • Table 35. Asia Pacific Pigmented Lesion Treatment, by Type USD Million (2015-2020)
  • Table 36. Asia Pacific Pigmented Lesion Treatment, by Application USD Million (2015-2020)
  • Table 37. Asia Pacific Pigmented Lesion Treatment, by Treatment USD Million (2015-2020)
  • Table 38. Asia Pacific Pigmented Lesion Treatment, by Indication USD Million (2015-2020)
  • Table 39. China Pigmented Lesion Treatment, by Type USD Million (2015-2020)
  • Table 40. China Pigmented Lesion Treatment, by Application USD Million (2015-2020)
  • Table 41. China Pigmented Lesion Treatment, by Treatment USD Million (2015-2020)
  • Table 42. China Pigmented Lesion Treatment, by Indication USD Million (2015-2020)
  • Table 43. Japan Pigmented Lesion Treatment, by Type USD Million (2015-2020)
  • Table 44. Japan Pigmented Lesion Treatment, by Application USD Million (2015-2020)
  • Table 45. Japan Pigmented Lesion Treatment, by Treatment USD Million (2015-2020)
  • Table 46. Japan Pigmented Lesion Treatment, by Indication USD Million (2015-2020)
  • Table 47. India Pigmented Lesion Treatment, by Type USD Million (2015-2020)
  • Table 48. India Pigmented Lesion Treatment, by Application USD Million (2015-2020)
  • Table 49. India Pigmented Lesion Treatment, by Treatment USD Million (2015-2020)
  • Table 50. India Pigmented Lesion Treatment, by Indication USD Million (2015-2020)
  • Table 51. South Korea Pigmented Lesion Treatment, by Type USD Million (2015-2020)
  • Table 52. South Korea Pigmented Lesion Treatment, by Application USD Million (2015-2020)
  • Table 53. South Korea Pigmented Lesion Treatment, by Treatment USD Million (2015-2020)
  • Table 54. South Korea Pigmented Lesion Treatment, by Indication USD Million (2015-2020)
  • Table 55. Taiwan Pigmented Lesion Treatment, by Type USD Million (2015-2020)
  • Table 56. Taiwan Pigmented Lesion Treatment, by Application USD Million (2015-2020)
  • Table 57. Taiwan Pigmented Lesion Treatment, by Treatment USD Million (2015-2020)
  • Table 58. Taiwan Pigmented Lesion Treatment, by Indication USD Million (2015-2020)
  • Table 59. Australia Pigmented Lesion Treatment, by Type USD Million (2015-2020)
  • Table 60. Australia Pigmented Lesion Treatment, by Application USD Million (2015-2020)
  • Table 61. Australia Pigmented Lesion Treatment, by Treatment USD Million (2015-2020)
  • Table 62. Australia Pigmented Lesion Treatment, by Indication USD Million (2015-2020)
  • Table 63. Rest of Asia-Pacific Pigmented Lesion Treatment, by Type USD Million (2015-2020)
  • Table 64. Rest of Asia-Pacific Pigmented Lesion Treatment, by Application USD Million (2015-2020)
  • Table 65. Rest of Asia-Pacific Pigmented Lesion Treatment, by Treatment USD Million (2015-2020)
  • Table 66. Rest of Asia-Pacific Pigmented Lesion Treatment, by Indication USD Million (2015-2020)
  • Table 67. Europe Pigmented Lesion Treatment, by Country USD Million (2015-2020)
  • Table 68. Europe Pigmented Lesion Treatment, by Type USD Million (2015-2020)
  • Table 69. Europe Pigmented Lesion Treatment, by Application USD Million (2015-2020)
  • Table 70. Europe Pigmented Lesion Treatment, by Treatment USD Million (2015-2020)
  • Table 71. Europe Pigmented Lesion Treatment, by Indication USD Million (2015-2020)
  • Table 72. Germany Pigmented Lesion Treatment, by Type USD Million (2015-2020)
  • Table 73. Germany Pigmented Lesion Treatment, by Application USD Million (2015-2020)
  • Table 74. Germany Pigmented Lesion Treatment, by Treatment USD Million (2015-2020)
  • Table 75. Germany Pigmented Lesion Treatment, by Indication USD Million (2015-2020)
  • Table 76. France Pigmented Lesion Treatment, by Type USD Million (2015-2020)
  • Table 77. France Pigmented Lesion Treatment, by Application USD Million (2015-2020)
  • Table 78. France Pigmented Lesion Treatment, by Treatment USD Million (2015-2020)
  • Table 79. France Pigmented Lesion Treatment, by Indication USD Million (2015-2020)
  • Table 80. Italy Pigmented Lesion Treatment, by Type USD Million (2015-2020)
  • Table 81. Italy Pigmented Lesion Treatment, by Application USD Million (2015-2020)
  • Table 82. Italy Pigmented Lesion Treatment, by Treatment USD Million (2015-2020)
  • Table 83. Italy Pigmented Lesion Treatment, by Indication USD Million (2015-2020)
  • Table 84. United Kingdom Pigmented Lesion Treatment, by Type USD Million (2015-2020)
  • Table 85. United Kingdom Pigmented Lesion Treatment, by Application USD Million (2015-2020)
  • Table 86. United Kingdom Pigmented Lesion Treatment, by Treatment USD Million (2015-2020)
  • Table 87. United Kingdom Pigmented Lesion Treatment, by Indication USD Million (2015-2020)
  • Table 88. Netherlands Pigmented Lesion Treatment, by Type USD Million (2015-2020)
  • Table 89. Netherlands Pigmented Lesion Treatment, by Application USD Million (2015-2020)
  • Table 90. Netherlands Pigmented Lesion Treatment, by Treatment USD Million (2015-2020)
  • Table 91. Netherlands Pigmented Lesion Treatment, by Indication USD Million (2015-2020)
  • Table 92. Rest of Europe Pigmented Lesion Treatment, by Type USD Million (2015-2020)
  • Table 93. Rest of Europe Pigmented Lesion Treatment, by Application USD Million (2015-2020)
  • Table 94. Rest of Europe Pigmented Lesion Treatment, by Treatment USD Million (2015-2020)
  • Table 95. Rest of Europe Pigmented Lesion Treatment, by Indication USD Million (2015-2020)
  • Table 96. MEA Pigmented Lesion Treatment, by Country USD Million (2015-2020)
  • Table 97. MEA Pigmented Lesion Treatment, by Type USD Million (2015-2020)
  • Table 98. MEA Pigmented Lesion Treatment, by Application USD Million (2015-2020)
  • Table 99. MEA Pigmented Lesion Treatment, by Treatment USD Million (2015-2020)
  • Table 100. MEA Pigmented Lesion Treatment, by Indication USD Million (2015-2020)
  • Table 101. Middle East Pigmented Lesion Treatment, by Type USD Million (2015-2020)
  • Table 102. Middle East Pigmented Lesion Treatment, by Application USD Million (2015-2020)
  • Table 103. Middle East Pigmented Lesion Treatment, by Treatment USD Million (2015-2020)
  • Table 104. Middle East Pigmented Lesion Treatment, by Indication USD Million (2015-2020)
  • Table 105. Africa Pigmented Lesion Treatment, by Type USD Million (2015-2020)
  • Table 106. Africa Pigmented Lesion Treatment, by Application USD Million (2015-2020)
  • Table 107. Africa Pigmented Lesion Treatment, by Treatment USD Million (2015-2020)
  • Table 108. Africa Pigmented Lesion Treatment, by Indication USD Million (2015-2020)
  • Table 109. North America Pigmented Lesion Treatment, by Country USD Million (2015-2020)
  • Table 110. North America Pigmented Lesion Treatment, by Type USD Million (2015-2020)
  • Table 111. North America Pigmented Lesion Treatment, by Application USD Million (2015-2020)
  • Table 112. North America Pigmented Lesion Treatment, by Treatment USD Million (2015-2020)
  • Table 113. North America Pigmented Lesion Treatment, by Indication USD Million (2015-2020)
  • Table 114. United States Pigmented Lesion Treatment, by Type USD Million (2015-2020)
  • Table 115. United States Pigmented Lesion Treatment, by Application USD Million (2015-2020)
  • Table 116. United States Pigmented Lesion Treatment, by Treatment USD Million (2015-2020)
  • Table 117. United States Pigmented Lesion Treatment, by Indication USD Million (2015-2020)
  • Table 118. Canada Pigmented Lesion Treatment, by Type USD Million (2015-2020)
  • Table 119. Canada Pigmented Lesion Treatment, by Application USD Million (2015-2020)
  • Table 120. Canada Pigmented Lesion Treatment, by Treatment USD Million (2015-2020)
  • Table 121. Canada Pigmented Lesion Treatment, by Indication USD Million (2015-2020)
  • Table 122. Mexico Pigmented Lesion Treatment, by Type USD Million (2015-2020)
  • Table 123. Mexico Pigmented Lesion Treatment, by Application USD Million (2015-2020)
  • Table 124. Mexico Pigmented Lesion Treatment, by Treatment USD Million (2015-2020)
  • Table 125. Mexico Pigmented Lesion Treatment, by Indication USD Million (2015-2020)
  • Table 126. Company Basic Information, Sales Area and Its Competitors
  • Table 127. Company Basic Information, Sales Area and Its Competitors
  • Table 128. Company Basic Information, Sales Area and Its Competitors
  • Table 129. Company Basic Information, Sales Area and Its Competitors
  • Table 130. Company Basic Information, Sales Area and Its Competitors
  • Table 131. Company Basic Information, Sales Area and Its Competitors
  • Table 132. Company Basic Information, Sales Area and Its Competitors
  • Table 133. Company Basic Information, Sales Area and Its Competitors
  • Table 134. Company Basic Information, Sales Area and Its Competitors
  • Table 135. Company Basic Information, Sales Area and Its Competitors
  • Table 136. Pigmented Lesion Treatment: by Type(USD Million)
  • Table 137. Pigmented Lesion Treatment Energy Based Devices , by Region USD Million (2021-2026)
  • Table 138. Pigmented Lesion Treatment RF Devices , by Region USD Million (2021-2026)
  • Table 139. Pigmented Lesion Treatment Ultrasound Devices , by Region USD Million (2021-2026)
  • Table 140. Pigmented Lesion Treatment IPL Devices , by Region USD Million (2021-2026)
  • Table 141. Pigmented Lesion Treatment: by Application(USD Million)
  • Table 142. Pigmented Lesion Treatment Dermatology Clinics , by Region USD Million (2021-2026)
  • Table 143. Pigmented Lesion Treatment Beauty Clinics , by Region USD Million (2021-2026)
  • Table 144. Pigmented Lesion Treatment Hospitals , by Region USD Million (2021-2026)
  • Table 145. Pigmented Lesion Treatment: by Treatment(USD Million)
  • Table 146. Pigmented Lesion Treatment Laser Treatment , by Region USD Million (2021-2026)
  • Table 147. Pigmented Lesion Treatment Light-based Treatment , by Region USD Million (2021-2026)
  • Table 148. Pigmented Lesion Treatment Others , by Region USD Million (2021-2026)
  • Table 149. Pigmented Lesion Treatment: by Indication(USD Million)
  • Table 150. Pigmented Lesion Treatment Non-Metalic Lesions , by Region USD Million (2021-2026)
  • Table 151. Pigmented Lesion Treatment Melanocytic Lesions , by Region USD Million (2021-2026)
  • Table 152. South America Pigmented Lesion Treatment, by Country USD Million (2021-2026)
  • Table 153. South America Pigmented Lesion Treatment, by Type USD Million (2021-2026)
  • Table 154. South America Pigmented Lesion Treatment, by Application USD Million (2021-2026)
  • Table 155. South America Pigmented Lesion Treatment, by Treatment USD Million (2021-2026)
  • Table 156. South America Pigmented Lesion Treatment, by Indication USD Million (2021-2026)
  • Table 157. Brazil Pigmented Lesion Treatment, by Type USD Million (2021-2026)
  • Table 158. Brazil Pigmented Lesion Treatment, by Application USD Million (2021-2026)
  • Table 159. Brazil Pigmented Lesion Treatment, by Treatment USD Million (2021-2026)
  • Table 160. Brazil Pigmented Lesion Treatment, by Indication USD Million (2021-2026)
  • Table 161. Argentina Pigmented Lesion Treatment, by Type USD Million (2021-2026)
  • Table 162. Argentina Pigmented Lesion Treatment, by Application USD Million (2021-2026)
  • Table 163. Argentina Pigmented Lesion Treatment, by Treatment USD Million (2021-2026)
  • Table 164. Argentina Pigmented Lesion Treatment, by Indication USD Million (2021-2026)
  • Table 165. Rest of South America Pigmented Lesion Treatment, by Type USD Million (2021-2026)
  • Table 166. Rest of South America Pigmented Lesion Treatment, by Application USD Million (2021-2026)
  • Table 167. Rest of South America Pigmented Lesion Treatment, by Treatment USD Million (2021-2026)
  • Table 168. Rest of South America Pigmented Lesion Treatment, by Indication USD Million (2021-2026)
  • Table 169. Asia Pacific Pigmented Lesion Treatment, by Country USD Million (2021-2026)
  • Table 170. Asia Pacific Pigmented Lesion Treatment, by Type USD Million (2021-2026)
  • Table 171. Asia Pacific Pigmented Lesion Treatment, by Application USD Million (2021-2026)
  • Table 172. Asia Pacific Pigmented Lesion Treatment, by Treatment USD Million (2021-2026)
  • Table 173. Asia Pacific Pigmented Lesion Treatment, by Indication USD Million (2021-2026)
  • Table 174. China Pigmented Lesion Treatment, by Type USD Million (2021-2026)
  • Table 175. China Pigmented Lesion Treatment, by Application USD Million (2021-2026)
  • Table 176. China Pigmented Lesion Treatment, by Treatment USD Million (2021-2026)
  • Table 177. China Pigmented Lesion Treatment, by Indication USD Million (2021-2026)
  • Table 178. Japan Pigmented Lesion Treatment, by Type USD Million (2021-2026)
  • Table 179. Japan Pigmented Lesion Treatment, by Application USD Million (2021-2026)
  • Table 180. Japan Pigmented Lesion Treatment, by Treatment USD Million (2021-2026)
  • Table 181. Japan Pigmented Lesion Treatment, by Indication USD Million (2021-2026)
  • Table 182. India Pigmented Lesion Treatment, by Type USD Million (2021-2026)
  • Table 183. India Pigmented Lesion Treatment, by Application USD Million (2021-2026)
  • Table 184. India Pigmented Lesion Treatment, by Treatment USD Million (2021-2026)
  • Table 185. India Pigmented Lesion Treatment, by Indication USD Million (2021-2026)
  • Table 186. South Korea Pigmented Lesion Treatment, by Type USD Million (2021-2026)
  • Table 187. South Korea Pigmented Lesion Treatment, by Application USD Million (2021-2026)
  • Table 188. South Korea Pigmented Lesion Treatment, by Treatment USD Million (2021-2026)
  • Table 189. South Korea Pigmented Lesion Treatment, by Indication USD Million (2021-2026)
  • Table 190. Taiwan Pigmented Lesion Treatment, by Type USD Million (2021-2026)
  • Table 191. Taiwan Pigmented Lesion Treatment, by Application USD Million (2021-2026)
  • Table 192. Taiwan Pigmented Lesion Treatment, by Treatment USD Million (2021-2026)
  • Table 193. Taiwan Pigmented Lesion Treatment, by Indication USD Million (2021-2026)
  • Table 194. Australia Pigmented Lesion Treatment, by Type USD Million (2021-2026)
  • Table 195. Australia Pigmented Lesion Treatment, by Application USD Million (2021-2026)
  • Table 196. Australia Pigmented Lesion Treatment, by Treatment USD Million (2021-2026)
  • Table 197. Australia Pigmented Lesion Treatment, by Indication USD Million (2021-2026)
  • Table 198. Rest of Asia-Pacific Pigmented Lesion Treatment, by Type USD Million (2021-2026)
  • Table 199. Rest of Asia-Pacific Pigmented Lesion Treatment, by Application USD Million (2021-2026)
  • Table 200. Rest of Asia-Pacific Pigmented Lesion Treatment, by Treatment USD Million (2021-2026)
  • Table 201. Rest of Asia-Pacific Pigmented Lesion Treatment, by Indication USD Million (2021-2026)
  • Table 202. Europe Pigmented Lesion Treatment, by Country USD Million (2021-2026)
  • Table 203. Europe Pigmented Lesion Treatment, by Type USD Million (2021-2026)
  • Table 204. Europe Pigmented Lesion Treatment, by Application USD Million (2021-2026)
  • Table 205. Europe Pigmented Lesion Treatment, by Treatment USD Million (2021-2026)
  • Table 206. Europe Pigmented Lesion Treatment, by Indication USD Million (2021-2026)
  • Table 207. Germany Pigmented Lesion Treatment, by Type USD Million (2021-2026)
  • Table 208. Germany Pigmented Lesion Treatment, by Application USD Million (2021-2026)
  • Table 209. Germany Pigmented Lesion Treatment, by Treatment USD Million (2021-2026)
  • Table 210. Germany Pigmented Lesion Treatment, by Indication USD Million (2021-2026)
  • Table 211. France Pigmented Lesion Treatment, by Type USD Million (2021-2026)
  • Table 212. France Pigmented Lesion Treatment, by Application USD Million (2021-2026)
  • Table 213. France Pigmented Lesion Treatment, by Treatment USD Million (2021-2026)
  • Table 214. France Pigmented Lesion Treatment, by Indication USD Million (2021-2026)
  • Table 215. Italy Pigmented Lesion Treatment, by Type USD Million (2021-2026)
  • Table 216. Italy Pigmented Lesion Treatment, by Application USD Million (2021-2026)
  • Table 217. Italy Pigmented Lesion Treatment, by Treatment USD Million (2021-2026)
  • Table 218. Italy Pigmented Lesion Treatment, by Indication USD Million (2021-2026)
  • Table 219. United Kingdom Pigmented Lesion Treatment, by Type USD Million (2021-2026)
  • Table 220. United Kingdom Pigmented Lesion Treatment, by Application USD Million (2021-2026)
  • Table 221. United Kingdom Pigmented Lesion Treatment, by Treatment USD Million (2021-2026)
  • Table 222. United Kingdom Pigmented Lesion Treatment, by Indication USD Million (2021-2026)
  • Table 223. Netherlands Pigmented Lesion Treatment, by Type USD Million (2021-2026)
  • Table 224. Netherlands Pigmented Lesion Treatment, by Application USD Million (2021-2026)
  • Table 225. Netherlands Pigmented Lesion Treatment, by Treatment USD Million (2021-2026)
  • Table 226. Netherlands Pigmented Lesion Treatment, by Indication USD Million (2021-2026)
  • Table 227. Rest of Europe Pigmented Lesion Treatment, by Type USD Million (2021-2026)
  • Table 228. Rest of Europe Pigmented Lesion Treatment, by Application USD Million (2021-2026)
  • Table 229. Rest of Europe Pigmented Lesion Treatment, by Treatment USD Million (2021-2026)
  • Table 230. Rest of Europe Pigmented Lesion Treatment, by Indication USD Million (2021-2026)
  • Table 231. MEA Pigmented Lesion Treatment, by Country USD Million (2021-2026)
  • Table 232. MEA Pigmented Lesion Treatment, by Type USD Million (2021-2026)
  • Table 233. MEA Pigmented Lesion Treatment, by Application USD Million (2021-2026)
  • Table 234. MEA Pigmented Lesion Treatment, by Treatment USD Million (2021-2026)
  • Table 235. MEA Pigmented Lesion Treatment, by Indication USD Million (2021-2026)
  • Table 236. Middle East Pigmented Lesion Treatment, by Type USD Million (2021-2026)
  • Table 237. Middle East Pigmented Lesion Treatment, by Application USD Million (2021-2026)
  • Table 238. Middle East Pigmented Lesion Treatment, by Treatment USD Million (2021-2026)
  • Table 239. Middle East Pigmented Lesion Treatment, by Indication USD Million (2021-2026)
  • Table 240. Africa Pigmented Lesion Treatment, by Type USD Million (2021-2026)
  • Table 241. Africa Pigmented Lesion Treatment, by Application USD Million (2021-2026)
  • Table 242. Africa Pigmented Lesion Treatment, by Treatment USD Million (2021-2026)
  • Table 243. Africa Pigmented Lesion Treatment, by Indication USD Million (2021-2026)
  • Table 244. North America Pigmented Lesion Treatment, by Country USD Million (2021-2026)
  • Table 245. North America Pigmented Lesion Treatment, by Type USD Million (2021-2026)
  • Table 246. North America Pigmented Lesion Treatment, by Application USD Million (2021-2026)
  • Table 247. North America Pigmented Lesion Treatment, by Treatment USD Million (2021-2026)
  • Table 248. North America Pigmented Lesion Treatment, by Indication USD Million (2021-2026)
  • Table 249. United States Pigmented Lesion Treatment, by Type USD Million (2021-2026)
  • Table 250. United States Pigmented Lesion Treatment, by Application USD Million (2021-2026)
  • Table 251. United States Pigmented Lesion Treatment, by Treatment USD Million (2021-2026)
  • Table 252. United States Pigmented Lesion Treatment, by Indication USD Million (2021-2026)
  • Table 253. Canada Pigmented Lesion Treatment, by Type USD Million (2021-2026)
  • Table 254. Canada Pigmented Lesion Treatment, by Application USD Million (2021-2026)
  • Table 255. Canada Pigmented Lesion Treatment, by Treatment USD Million (2021-2026)
  • Table 256. Canada Pigmented Lesion Treatment, by Indication USD Million (2021-2026)
  • Table 257. Mexico Pigmented Lesion Treatment, by Type USD Million (2021-2026)
  • Table 258. Mexico Pigmented Lesion Treatment, by Application USD Million (2021-2026)
  • Table 259. Mexico Pigmented Lesion Treatment, by Treatment USD Million (2021-2026)
  • Table 260. Mexico Pigmented Lesion Treatment, by Indication USD Million (2021-2026)
  • Table 261. Research Programs/Design for This Report
  • Table 262. Key Data Information from Secondary Sources
  • Table 263. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Pigmented Lesion Treatment: by Type USD Million (2015-2020)
  • Figure 5. Global Pigmented Lesion Treatment: by Application USD Million (2015-2020)
  • Figure 6. Global Pigmented Lesion Treatment: by Treatment USD Million (2015-2020)
  • Figure 7. Global Pigmented Lesion Treatment: by Indication USD Million (2015-2020)
  • Figure 8. South America Pigmented Lesion Treatment Share (%), by Country
  • Figure 9. Asia Pacific Pigmented Lesion Treatment Share (%), by Country
  • Figure 10. Europe Pigmented Lesion Treatment Share (%), by Country
  • Figure 11. MEA Pigmented Lesion Treatment Share (%), by Country
  • Figure 12. North America Pigmented Lesion Treatment Share (%), by Country
  • Figure 13. Global Pigmented Lesion Treatment share by Players 2020 (%)
  • Figure 14. Global Pigmented Lesion Treatment share by Players (Top 3) 2020(%)
  • Figure 15. Global Pigmented Lesion Treatment share by Players (Top 5) 2020(%)
  • Figure 16. BCG Matrix for key Companies
  • Figure 17. Alma Lasers, Ltd. (Israel) Revenue, Net Income and Gross profit
  • Figure 18. Alma Lasers, Ltd. (Israel) Revenue: by Geography 2020
  • Figure 19. Sciton, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 20. Sciton, Inc. (United States) Revenue: by Geography 2020
  • Figure 21. EL.En. S.p.A. (Italy) Revenue, Net Income and Gross profit
  • Figure 22. EL.En. S.p.A. (Italy) Revenue: by Geography 2020
  • Figure 23. Lynton Lasers Ltd (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 24. Lynton Lasers Ltd (United Kingdom) Revenue: by Geography 2020
  • Figure 25. Solta Medical Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 26. Solta Medical Inc. (United States) Revenue: by Geography 2020
  • Figure 27. Lumenis Ltd. (Israel) Revenue, Net Income and Gross profit
  • Figure 28. Lumenis Ltd. (Israel) Revenue: by Geography 2020
  • Figure 29. Cynosure, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 30. Cynosure, Inc. (United States) Revenue: by Geography 2020
  • Figure 31. Strata Skin Sciences, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 32. Strata Skin Sciences, Inc. (United States) Revenue: by Geography 2020
  • Figure 33. Syneron Medical Ltd. (United States) Revenue, Net Income and Gross profit
  • Figure 34. Syneron Medical Ltd. (United States) Revenue: by Geography 2020
  • Figure 35. Lutronic Corporation (South Korea) Revenue, Net Income and Gross profit
  • Figure 36. Lutronic Corporation (South Korea) Revenue: by Geography 2020
  • Figure 37. Global Pigmented Lesion Treatment: by Type USD Million (2021-2026)
  • Figure 38. Global Pigmented Lesion Treatment: by Application USD Million (2021-2026)
  • Figure 39. Global Pigmented Lesion Treatment: by Treatment USD Million (2021-2026)
  • Figure 40. Global Pigmented Lesion Treatment: by Indication USD Million (2021-2026)
  • Figure 41. South America Pigmented Lesion Treatment Share (%), by Country
  • Figure 42. Asia Pacific Pigmented Lesion Treatment Share (%), by Country
  • Figure 43. Europe Pigmented Lesion Treatment Share (%), by Country
  • Figure 44. MEA Pigmented Lesion Treatment Share (%), by Country
  • Figure 45. North America Pigmented Lesion Treatment Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Alma Lasers, Ltd. (Israel)
  • Sciton, Inc. (United States)
  • EL.En. S.p.A. (Italy)
  • Lynton Lasers Ltd (United Kingdom)
  • Solta Medical Inc. (United States)
  • Lumenis Ltd. (Israel)
  • Cynosure, Inc. (United States)
  • Strata Skin Sciences, Inc. (United States)
  • Syneron Medical Ltd. (United States)
  • Lutronic Corporation (South Korea)
Additional players considered in the study are as follows:
Cutera Inc. (United States)
Select User Access Type

Key Highlights of Report


Jul 2021 249 Pages 59 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Pigmented Lesion Treatment Quantitative research analysis
Global Pigmented Lesion Treatment Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The Pigmented Lesion Treatment study can be customized to meet your requirements. The market size breakdown by type [Energy Based Devices, RF Devices, Ultrasound Devices and IPL Devices], by end use application [Dermatology Clinics, Beauty Clinics and Hospitals].
The Pigmented Lesion Treatment Market is gaining popularity and expected to see strong valuation by 2026.
According to AMA, the Global Pigmented Lesion Treatment market is expected to see growth rate of %.

Know More About Global Pigmented Lesion Treatment Report?

Have a Query? Click Here

Other Related Reports

Stretch Marks Treatment Comprehensive Study by Type (Topical Products (Oils, Creams, and Lotion), Lasers (Pulse-Dye Laser, Fractional Laser, and Others), Microdermabrasion, Others), Application (Hosp...
$ 3450
Animal Genetics Comprehensive Study by Type (Live Animals), Application (Genetic Typing, Genetic Trait Testing, Genetic Disease Testing), Genetic Testing (DNA Testing, DNA Typing, Genetic Disease Tes...
$ 3650
Botulism Treatment Comprehensive Study by Type (Antitoxin, Antibiotics, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Others), End User (Hospitals, Specialty Clinics, Others), Bo...
$ 3450
Brain Tumor Treatment Comprehensive Study by Treatment (Surgery, Radiation Therapy, Radiosurgery, Chemotherapy, Targeted Drug Therapy), End-user (Hospitals, Clinics, Ambulatory Surgery Centres), Diag...
$ 3650
Colorectal Cancer Comprehensive Study by Type (Lymphoma, Carcinoids, Turcot Syndrome, Adenocarcinoma, Juvenile Polyposis Coli, Peutz-Jeghers Syndrome (PJS), Familial Colorectal Cancer (FCC), Gastroin...
$ 3750
Extremity Reconstruction Comprehensive Study by Type (Upper Extremity (Shoulder Reconstruction(Partial Shoulder Replacement, Total Standard Replacement, Stemless Total Shoulder Replacement, Total Rev...
$ 3750